N-Phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (9) and related piperidine acetamide derivatives have good oral activity in the elevated plus maze, an animal model predictive of clinical efficacy for the treatment of anxiety. Modest affinity was observed for the neurokinin NK-1 and 2 receptors, which are known to be involved in the regulation of mood and emotion.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.02.027 | DOI Listing |
Publication Analysis
Top Keywords
diarylacetylene piperidinyl
4
piperidinyl amides
4
amides novel
4
novel anxiolytics
4
anxiolytics n-phenyl-2-[1-[3-2-pyridinylethynylbenzoyl]-4-piperidine]acetamide
4
n-phenyl-2-[1-[3-2-pyridinylethynylbenzoyl]-4-piperidine]acetamide piperidine
4
piperidine acetamide
4
acetamide derivatives
4
derivatives good
4
good oral
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!